Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

HUGE upside in Ktruda ...continue to see the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JA2626 Member Profile
 
Followed By 0
Posts 60
Boards Moderated 0
Alias Born 01/16/19
160x600 placeholder
Merck on Pace for Largest Percent Decrease Since October 2017 -- Data Talk Dow Jones News - 7/11/2019 2:43:00 PM
Merck Highlights Commitment to HIV Research with Presentations for Investigational Anti-HIV Agent MK-8591 at IAS 2019 Business Wire - 7/10/2019 6:45:00 AM
Drugmakers Rise After Trump Pricing Rule Is Blocked Dow Jones News - 7/9/2019 1:58:00 PM
Merck Sees FDA OK for Six-Week Keytruda Dosing in Six Indications Dow Jones News - 7/9/2019 7:27:00 AM
FDA Accepts Merck’s Supplemental Biologics License Applications for KEYTRUDA® (pembrolizumab) Six-Week Dosing Schedule for... Business Wire - 7/9/2019 6:45:00 AM
Trump Rule Requiring Drug Prices in TV Ads Blocked -- Update Dow Jones News - 7/8/2019 10:25:00 PM
Trump Rule Requiring Drug Prices in TV Ads Blocked Dow Jones News - 7/8/2019 9:34:00 PM
Skyhawk Therapeutics Says to Work With Merck to Develop Drug Candidates Dow Jones News - 7/8/2019 8:29:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:25:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:23:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:20:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:17:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:08:56 PM
Merck to Hold Second-Quarter 2019 Sales and Earnings Conference Call on July 30 Business Wire - 7/1/2019 6:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/27/2019 5:06:23 PM
Merck Says CDC Committee Recommends HPV Vaccine for Men and Women Through 26 Dow Jones News - 6/26/2019 6:40:00 PM
CDC Advisory Committee on Immunization Practices (ACIP) Votes to Provisionally Recommend Shared Clinical Decision-Making for ... Business Wire - 6/26/2019 4:45:00 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/20/2019 3:25:26 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/20/2019 3:23:46 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/20/2019 3:22:15 PM
Merck Hosts 2019 Investor Day Outlining Bus. Momentum, Strong Expected Growth & Focus on Innovative Research & Development Business Wire - 6/20/2019 6:45:00 AM
Merck Seeks Deals As It Expands Its Cancer Treatments -- WSJ Dow Jones News - 6/20/2019 3:02:00 AM
AstraZeneca & Merck’s LYNPARZA® (olaparib) Approved in Japan as First-Line Maintenance Therapy in Patients with BRCA-Mutat... Business Wire - 6/19/2019 6:45:00 AM
Merck Seeks More Deals Dow Jones News - 6/19/2019 5:59:00 AM
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Monotherapy for Patients with Metastatic Small Cell Lung Cancer (SCLC) w... Business Wire - 6/18/2019 6:45:00 AM
JA2626   Wednesday, 03/13/19 04:16:17 PM
Re: None
Post # of 469 
HUGE upside in Ktruda ...continue to see the upside to 90 within the April timeframe ....once that break out happens ...who knows where it ends up ...watch for other acquisitions as well ...building the funnel big time

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist